We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pfizer To Pay $2.3B In Bextra Off-Label Marketing Suit

Law360 (January 27, 2009, 12:00 AM EST) -- Pfizer Inc. has agreed to pay $2.3 billion to settle allegations that it improperly marketed the now-defunct anti-inflammatory drug Bextra, the pharmaceutical giant disclosed Monday.

The settlement, which still needs court...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.